Table 2. The distribution of expression for each lamin in the patient cohort.
Number of patients | ||||
---|---|---|---|---|
Marker | GS* group | Low expression | High expression | Total |
Lamin A | IHC grade 0–1 | IHC grade 2–3 | ||
Entire group | 251 (52.0%) | 232 (48.0%) | 483 | |
Subgroup (GS>6) | 141 (50.0%) | 141 (50.0%) | 282 | |
Lamin C | IHC grade 0 | IHC grade 1–3 | ||
Entire group | 41 (22.9%) | 138 (77.1%) | 179 | |
Subgroup (GS>6) | 22 (21.4%) | 81 (78.6%) | 103 | |
Lamin B1 | IHC grade 0–2 | IHC grade 3 | ||
Entire group | 142 (30.3%) | 327 (69.7%) | 469 | |
Subgroup (GS>6) | 82 (30.0%) | 191 (70.0%) | 273 | |
Lamin B2 | IHC grade 0–1 | IHC grade 2–3 | ||
Entire group | 169 (37.5%) | 282 (62.5%) | 451 | |
Subgroup (GS>6) | 88 (33.5%) | 175 (66.5%) | 263 |
*GS = Gleason score